

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.32177297 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.80992713 |
| 3 | vocalization behavior (GO:0071625) | 4.67700982 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 4.65308090 |
| 5 | central nervous system myelination (GO:0022010) | 4.65308090 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.30152619 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.23767696 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.21369383 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.20978703 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.17684849 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 4.10553561 |
| 12 | L-amino acid import (GO:0043092) | 4.10178862 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 3.96725104 |
| 14 | presynaptic membrane assembly (GO:0097105) | 3.95241793 |
| 15 | neuron recognition (GO:0008038) | 3.92838137 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.92467825 |
| 17 | nucleobase catabolic process (GO:0046113) | 3.88128824 |
| 18 | protein localization to synapse (GO:0035418) | 3.87316010 |
| 19 | presynaptic membrane organization (GO:0097090) | 3.85718657 |
| 20 | glutamate secretion (GO:0014047) | 3.84676295 |
| 21 | neuronal action potential propagation (GO:0019227) | 3.79438179 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.76983016 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 3.76021493 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.74678609 |
| 25 | axonal fasciculation (GO:0007413) | 3.70807400 |
| 26 | transmission of nerve impulse (GO:0019226) | 3.68490039 |
| 27 | amino acid import (GO:0043090) | 3.64056790 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.62729540 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.61024413 |
| 30 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.59087410 |
| 31 | synaptic vesicle maturation (GO:0016188) | 3.54700886 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48575625 |
| 33 | exploration behavior (GO:0035640) | 3.47353729 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.46002133 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.44023130 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 3.39726127 |
| 37 | layer formation in cerebral cortex (GO:0021819) | 3.38542209 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.36071506 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.34621874 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.33810700 |
| 41 | establishment of mitochondrion localization (GO:0051654) | 3.29946532 |
| 42 | retinal ganglion cell axon guidance (GO:0031290) | 3.22704318 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.22127058 |
| 44 | negative regulation of neurotransmitter transport (GO:0051589) | 3.19945905 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.19724920 |
| 46 | auditory behavior (GO:0031223) | 3.17944615 |
| 47 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.16813034 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.16445642 |
| 49 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.16116292 |
| 50 | long-term memory (GO:0007616) | 3.15920858 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.11882978 |
| 52 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11625368 |
| 53 | C4-dicarboxylate transport (GO:0015740) | 3.10576880 |
| 54 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.10572222 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08923392 |
| 56 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.04829676 |
| 57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04607658 |
| 58 | neuronal ion channel clustering (GO:0045161) | 3.03924093 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.02948767 |
| 60 | limb bud formation (GO:0060174) | 3.02248418 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.00943330 |
| 62 | neuronal action potential (GO:0019228) | 2.99504369 |
| 63 | behavioral response to nicotine (GO:0035095) | 2.99335753 |
| 64 | myelination (GO:0042552) | 2.97077227 |
| 65 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.95978348 |
| 66 | dendrite morphogenesis (GO:0048813) | 2.95747034 |
| 67 | glycosphingolipid biosynthetic process (GO:0006688) | 2.94690063 |
| 68 | neuromuscular synaptic transmission (GO:0007274) | 2.94668513 |
| 69 | membrane depolarization during action potential (GO:0086010) | 2.94552108 |
| 70 | regulation of synapse structural plasticity (GO:0051823) | 2.94141636 |
| 71 | protein polyglutamylation (GO:0018095) | 2.94062467 |
| 72 | regulation of postsynaptic membrane potential (GO:0060078) | 2.93344644 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 2.92595040 |
| 74 | adult walking behavior (GO:0007628) | 2.91469620 |
| 75 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90871551 |
| 76 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.90772744 |
| 77 | ensheathment of neurons (GO:0007272) | 2.90049553 |
| 78 | axon ensheathment (GO:0008366) | 2.90049553 |
| 79 | neurotransmitter secretion (GO:0007269) | 2.89800197 |
| 80 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.89653405 |
| 81 | short-term memory (GO:0007614) | 2.88990864 |
| 82 | response to auditory stimulus (GO:0010996) | 2.88877612 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 2.88475979 |
| 84 | mechanosensory behavior (GO:0007638) | 2.88188120 |
| 85 | cerebellar granule cell differentiation (GO:0021707) | 2.85123859 |
| 86 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.82898772 |
| 87 | positive regulation of membrane potential (GO:0045838) | 2.82474214 |
| 88 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.82204381 |
| 89 | glycerophospholipid catabolic process (GO:0046475) | 2.79652198 |
| 90 | regulation of dendritic spine development (GO:0060998) | 2.79398141 |
| 91 | positive regulation of synapse assembly (GO:0051965) | 2.79174004 |
| 92 | synapse organization (GO:0050808) | 2.77416226 |
| 93 | startle response (GO:0001964) | 2.76879302 |
| 94 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76636093 |
| 95 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.76410135 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.76191932 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74311378 |
| 98 | central nervous system neuron axonogenesis (GO:0021955) | 2.72435556 |
| 99 | learning (GO:0007612) | 2.69999818 |
| 100 | synapse assembly (GO:0007416) | 2.68793732 |
| 101 | acidic amino acid transport (GO:0015800) | 2.67696277 |
| 102 | dendrite development (GO:0016358) | 2.67567700 |
| 103 | neurotransmitter transport (GO:0006836) | 2.67214481 |
| 104 | neurotransmitter uptake (GO:0001504) | 2.67021945 |
| 105 | positive regulation of dendritic spine development (GO:0060999) | 2.65692076 |
| 106 | response to histamine (GO:0034776) | 2.65369890 |
| 107 | dendritic spine organization (GO:0097061) | 2.64036183 |
| 108 | regulation of vesicle fusion (GO:0031338) | 2.63710540 |
| 109 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.62835872 |
| 110 | protein localization to cilium (GO:0061512) | 2.62022120 |
| 111 | cell migration in hindbrain (GO:0021535) | 2.61597933 |
| 112 | myelination in peripheral nervous system (GO:0022011) | 2.61482853 |
| 113 | peripheral nervous system axon ensheathment (GO:0032292) | 2.61482853 |
| 114 | regulation of synaptic transmission (GO:0050804) | 2.60616218 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.60202646 |
| 116 | regulation of glutamate secretion (GO:0014048) | 2.59635294 |
| 117 | apical protein localization (GO:0045176) | 2.59020529 |
| 118 | negative regulation of axonogenesis (GO:0050771) | 2.58509118 |
| 119 | membrane assembly (GO:0071709) | 2.58062218 |
| 120 | behavioral defense response (GO:0002209) | 2.57215236 |
| 121 | behavioral fear response (GO:0001662) | 2.57215236 |
| 122 | retinal cone cell development (GO:0046549) | 2.55336411 |
| 123 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.53387195 |
| 124 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.50332316 |
| 125 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.50307059 |
| 126 | somite development (GO:0061053) | 2.48877343 |
| 127 | behavioral response to ethanol (GO:0048149) | 2.47430832 |
| 128 | nonmotile primary cilium assembly (GO:0035058) | 2.46716046 |
| 129 | regulation of synapse assembly (GO:0051963) | 2.46601141 |
| 130 | regulation of cell communication by electrical coupling (GO:0010649) | 2.45976227 |
| 131 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.44747925 |
| 132 | mitochondrion transport along microtubule (GO:0047497) | 2.44747925 |
| 133 | cyclic nucleotide catabolic process (GO:0009214) | 2.43913844 |
| 134 | regulation of respiratory system process (GO:0044065) | 2.42351118 |
| 135 | adult behavior (GO:0030534) | 2.41937279 |
| 136 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.41223389 |
| 137 | intraciliary transport (GO:0042073) | 2.41034070 |
| 138 | positive regulation of amino acid transport (GO:0051957) | 2.40825417 |
| 139 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.39460409 |
| 140 | epithelial cilium movement (GO:0003351) | 2.38086738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.49047234 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.69973987 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90345902 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86594894 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.79054423 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51437048 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51437048 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45375153 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43746680 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36642229 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36298138 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30028130 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28743133 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25303488 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18387981 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17648073 |
| 17 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09192426 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07280972 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96105624 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95736618 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93833823 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88768777 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87529636 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85765088 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83301477 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79615359 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72997265 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71688924 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71005567 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69430118 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69288799 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67468580 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67064929 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66621905 |
| 35 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65440213 |
| 36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65308166 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65282938 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62874380 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.57029374 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55812510 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.53691082 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52970530 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51178854 |
| 44 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.50622201 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49090364 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47168492 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46718856 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42969350 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41774519 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41519115 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40850080 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40587355 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37855383 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35573551 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34044789 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33445771 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33356391 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.32979337 |
| 59 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30791173 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29153494 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28466450 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27244810 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23444765 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22976540 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22580210 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22580210 |
| 67 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20656937 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20312673 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20047218 |
| 70 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18292511 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16892727 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16599186 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15984872 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15667331 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15348356 |
| 76 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15337742 |
| 77 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14463730 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13827474 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12765686 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12564927 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12553078 |
| 82 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12462997 |
| 83 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11232214 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10951062 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10548225 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10383398 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10383398 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09531937 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09306035 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09118530 |
| 91 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08304729 |
| 92 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07422241 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06942433 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05942168 |
| 95 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05647796 |
| 96 | AR_19668381_ChIP-Seq_PC3_Human | 1.04463630 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04428551 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03827713 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03748460 |
| 100 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03469536 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03201931 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02140212 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01609069 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01589115 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99699794 |
| 106 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98025564 |
| 107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96840035 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96513656 |
| 109 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95811397 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 0.95756964 |
| 111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95163278 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92724417 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92088666 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91387642 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91024329 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90738448 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90734313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.05325596 |
| 2 | MP0003880_abnormal_central_pattern | 4.67168315 |
| 3 | MP0004270_analgesia | 3.54744740 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.45290242 |
| 5 | MP0009745_abnormal_behavioral_response | 2.96967271 |
| 6 | MP0002064_seizures | 2.84758152 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.82493047 |
| 8 | MP0001486_abnormal_startle_reflex | 2.70858011 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.57132334 |
| 10 | MP0009046_muscle_twitch | 2.53228284 |
| 11 | MP0002272_abnormal_nervous_system | 2.52526379 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.38727773 |
| 13 | MP0000778_abnormal_nervous_system | 2.32923160 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.30933301 |
| 15 | MP0001529_abnormal_vocalization | 2.22029966 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.18409086 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.10487826 |
| 18 | MP0003329_amyloid_beta_deposits | 2.02732634 |
| 19 | MP0002736_abnormal_nociception_after | 2.01730945 |
| 20 | MP0001905_abnormal_dopamine_level | 1.97414707 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.94047055 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.90324387 |
| 23 | MP0004885_abnormal_endolymph | 1.83770866 |
| 24 | MP0002822_catalepsy | 1.83286284 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.82663178 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.82404585 |
| 27 | MP0001970_abnormal_pain_threshold | 1.72131174 |
| 28 | MP0000920_abnormal_myelination | 1.66858694 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.64734950 |
| 30 | MP0001984_abnormal_olfaction | 1.64068713 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.62607904 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.62193696 |
| 33 | MP0002184_abnormal_innervation | 1.60811614 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.60525712 |
| 35 | MP0008569_lethality_at_weaning | 1.57624365 |
| 36 | MP0004742_abnormal_vestibular_system | 1.56830350 |
| 37 | MP0004133_heterotaxia | 1.48702600 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.47756964 |
| 39 | MP0000955_abnormal_spinal_cord | 1.47010732 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.46540973 |
| 41 | MP0004924_abnormal_behavior | 1.46540973 |
| 42 | MP0005171_absent_coat_pigmentation | 1.45827364 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.45696654 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.44416365 |
| 45 | MP0003690_abnormal_glial_cell | 1.43618022 |
| 46 | MP0004142_abnormal_muscle_tone | 1.37965378 |
| 47 | MP0003121_genomic_imprinting | 1.37091919 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.35525082 |
| 49 | MP0000751_myopathy | 1.35156053 |
| 50 | MP0004858_abnormal_nervous_system | 1.34652542 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.33111136 |
| 52 | MP0003787_abnormal_imprinting | 1.29078448 |
| 53 | MP0001188_hyperpigmentation | 1.27590923 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.26680677 |
| 55 | MP0003634_abnormal_glial_cell | 1.23986609 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.23242002 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.22260280 |
| 58 | MP0003631_nervous_system_phenotype | 1.20746288 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.20354059 |
| 60 | MP0000749_muscle_degeneration | 1.19778002 |
| 61 | MP0003632_abnormal_nervous_system | 1.18883484 |
| 62 | MP0002152_abnormal_brain_morphology | 1.17021656 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.16159812 |
| 64 | MP0005253_abnormal_eye_physiology | 1.15303007 |
| 65 | MP0003633_abnormal_nervous_system | 1.14519676 |
| 66 | MP0002102_abnormal_ear_morphology | 1.14082849 |
| 67 | MP0005409_darkened_coat_color | 1.14000715 |
| 68 | MP0005248_abnormal_Harderian_gland | 1.12787353 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.09856281 |
| 70 | MP0003136_yellow_coat_color | 1.09768800 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 1.05363358 |
| 72 | MP0002752_abnormal_somatic_nervous | 1.05266571 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.04920212 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.04010208 |
| 75 | MP0002751_abnormal_autonomic_nervous | 1.01842218 |
| 76 | MP0002229_neurodegeneration | 1.01604586 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 1.00331890 |
| 78 | MP0002234_abnormal_pharynx_morphology | 0.98701166 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 0.97003419 |
| 80 | MP0005187_abnormal_penis_morphology | 0.93206079 |
| 81 | MP0000026_abnormal_inner_ear | 0.92940422 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.91347619 |
| 83 | MP0001177_atelectasis | 0.89700810 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.88826094 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 0.85766323 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.84609689 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.83915482 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.83840136 |
| 89 | MP0005499_abnormal_olfactory_system | 0.83457582 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.83457582 |
| 91 | MP0000049_abnormal_middle_ear | 0.82371766 |
| 92 | MP0005620_abnormal_muscle_contractility | 0.81776664 |
| 93 | MP0003879_abnormal_hair_cell | 0.81397158 |
| 94 | MP0004484_altered_response_of | 0.79365397 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.78841420 |
| 96 | MP0000462_abnormal_digestive_system | 0.78658916 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.78436273 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.78273107 |
| 99 | MP0003938_abnormal_ear_development | 0.77227977 |
| 100 | MP0003861_abnormal_nervous_system | 0.77056822 |
| 101 | MP0004085_abnormal_heartbeat | 0.77038976 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.76866216 |
| 103 | MP0005410_abnormal_fertilization | 0.75721584 |
| 104 | MP0004043_abnormal_pH_regulation | 0.75407035 |
| 105 | MP0002938_white_spotting | 0.74260763 |
| 106 | MP0003122_maternal_imprinting | 0.73176465 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.71066418 |
| 108 | MP0000604_amyloidosis | 0.70798852 |
| 109 | MP0003646_muscle_fatigue | 0.66182099 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.64798410 |
| 111 | MP0009250_abnormal_appendicular_skeleto | 0.64462033 |
| 112 | MP0002249_abnormal_larynx_morphology | 0.64390389 |
| 113 | MP0008874_decreased_physiological_sensi | 0.62993932 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.62378792 |
| 115 | MP0004233_abnormal_muscle_weight | 0.61922352 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.61887011 |
| 117 | MP0000566_synostosis | 0.60261066 |
| 118 | MP0005195_abnormal_posterior_eye | 0.58414350 |
| 119 | MP0001943_abnormal_respiration | 0.57571751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.89965941 |
| 2 | Myokymia (HP:0002411) | 4.84088655 |
| 3 | Atonic seizures (HP:0010819) | 4.19615584 |
| 4 | Focal seizures (HP:0007359) | 4.16334461 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.08886121 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.08826519 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.73952395 |
| 8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.73952395 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.53399163 |
| 10 | Febrile seizures (HP:0002373) | 3.47013102 |
| 11 | Hyperventilation (HP:0002883) | 3.27722793 |
| 12 | Abnormality of the corticospinal tract (HP:0002492) | 3.26147238 |
| 13 | Aplasia involving bones of the extremities (HP:0009825) | 3.25502099 |
| 14 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.25502099 |
| 15 | Aplasia of the phalanges of the hand (HP:0009802) | 3.25502099 |
| 16 | True hermaphroditism (HP:0010459) | 3.25398082 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.06406331 |
| 18 | Broad-based gait (HP:0002136) | 2.99949973 |
| 19 | Pancreatic fibrosis (HP:0100732) | 2.99835914 |
| 20 | Dysmetria (HP:0001310) | 2.96686105 |
| 21 | Insidious onset (HP:0003587) | 2.95417083 |
| 22 | Termporal pattern (HP:0011008) | 2.95417083 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 2.82871575 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 2.82871575 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.82260236 |
| 26 | Action tremor (HP:0002345) | 2.77252962 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 2.76372597 |
| 28 | Nephronophthisis (HP:0000090) | 2.69470920 |
| 29 | Dialeptic seizures (HP:0011146) | 2.68338104 |
| 30 | Absence seizures (HP:0002121) | 2.67859513 |
| 31 | Megalencephaly (HP:0001355) | 2.66680824 |
| 32 | Pancreatic cysts (HP:0001737) | 2.66057371 |
| 33 | Hemiparesis (HP:0001269) | 2.62033293 |
| 34 | Visual hallucinations (HP:0002367) | 2.60895970 |
| 35 | Ankle clonus (HP:0011448) | 2.58651242 |
| 36 | Gait imbalance (HP:0002141) | 2.53104822 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.50320268 |
| 38 | Spastic gait (HP:0002064) | 2.48704503 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.44447713 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 2.41443978 |
| 41 | Amblyopia (HP:0000646) | 2.39775684 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38316908 |
| 43 | Thickened helices (HP:0000391) | 2.34454692 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.32148855 |
| 45 | Excessive salivation (HP:0003781) | 2.31977741 |
| 46 | Drooling (HP:0002307) | 2.31977741 |
| 47 | Retinal dysplasia (HP:0007973) | 2.30861159 |
| 48 | Chronic hepatic failure (HP:0100626) | 2.29998653 |
| 49 | Truncal ataxia (HP:0002078) | 2.28982780 |
| 50 | Diplopia (HP:0000651) | 2.26509276 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.26509276 |
| 52 | Fetal akinesia sequence (HP:0001989) | 2.25145428 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24624656 |
| 54 | Scanning speech (HP:0002168) | 2.22033258 |
| 55 | Absent speech (HP:0001344) | 2.21717309 |
| 56 | Lissencephaly (HP:0001339) | 2.20877822 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.20467756 |
| 58 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.19756429 |
| 59 | Congenital primary aphakia (HP:0007707) | 2.19431975 |
| 60 | Abnormal hair whorl (HP:0010721) | 2.19108478 |
| 61 | Genital tract atresia (HP:0001827) | 2.19095156 |
| 62 | Absent/shortened dynein arms (HP:0200106) | 2.17284011 |
| 63 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17284011 |
| 64 | Vaginal atresia (HP:0000148) | 2.16198625 |
| 65 | Lower limb muscle weakness (HP:0007340) | 2.15878068 |
| 66 | Abnormality of the renal medulla (HP:0100957) | 2.15276893 |
| 67 | Limb dystonia (HP:0002451) | 2.14631393 |
| 68 | Polyphagia (HP:0002591) | 2.12705078 |
| 69 | Mutism (HP:0002300) | 2.09831748 |
| 70 | Pachygyria (HP:0001302) | 2.09361118 |
| 71 | Ulnar claw (HP:0001178) | 2.09359446 |
| 72 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.08213212 |
| 73 | Abnormal ciliary motility (HP:0012262) | 2.07339403 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 2.06062077 |
| 75 | Intention tremor (HP:0002080) | 2.05988118 |
| 76 | Specific learning disability (HP:0001328) | 2.04078367 |
| 77 | Postaxial hand polydactyly (HP:0001162) | 2.03999282 |
| 78 | Exercise-induced muscle cramps (HP:0003710) | 2.02894250 |
| 79 | Anxiety (HP:0000739) | 2.02412651 |
| 80 | Type II lissencephaly (HP:0007260) | 2.02120843 |
| 81 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00742693 |
| 82 | Abnormality of the labia minora (HP:0012880) | 2.00227088 |
| 83 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.99958094 |
| 84 | Genetic anticipation (HP:0003743) | 1.99206277 |
| 85 | Sensory axonal neuropathy (HP:0003390) | 1.98327695 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 1.97025909 |
| 87 | Hepatoblastoma (HP:0002884) | 1.96523880 |
| 88 | Generalized myoclonic seizures (HP:0002123) | 1.94607314 |
| 89 | Urinary urgency (HP:0000012) | 1.90721189 |
| 90 | Pheochromocytoma (HP:0002666) | 1.88775984 |
| 91 | Clumsiness (HP:0002312) | 1.87491221 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84000782 |
| 93 | Hypoplastic nipples (HP:0002557) | 1.83310244 |
| 94 | Papillary thyroid carcinoma (HP:0002895) | 1.83294605 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.83137814 |
| 96 | Broad foot (HP:0001769) | 1.82702873 |
| 97 | Cystic liver disease (HP:0006706) | 1.82518575 |
| 98 | Split foot (HP:0001839) | 1.82343207 |
| 99 | Occipital encephalocele (HP:0002085) | 1.82309087 |
| 100 | Sleep apnea (HP:0010535) | 1.82160061 |
| 101 | Postaxial foot polydactyly (HP:0001830) | 1.82059316 |
| 102 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.80740892 |
| 103 | Spastic tetraplegia (HP:0002510) | 1.80505126 |
| 104 | Torticollis (HP:0000473) | 1.80431970 |
| 105 | Anosmia (HP:0000458) | 1.80166762 |
| 106 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.80017737 |
| 107 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.80017737 |
| 108 | Depression (HP:0000716) | 1.79747085 |
| 109 | Calf muscle hypertrophy (HP:0008981) | 1.79490902 |
| 110 | Delusions (HP:0000746) | 1.79372485 |
| 111 | Left ventricular hypertrophy (HP:0001712) | 1.78787356 |
| 112 | Progressive inability to walk (HP:0002505) | 1.78221687 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77420471 |
| 114 | Sclerocornea (HP:0000647) | 1.75691279 |
| 115 | Narrow nasal bridge (HP:0000446) | 1.75656715 |
| 116 | Status epilepticus (HP:0002133) | 1.75030741 |
| 117 | Narrow forehead (HP:0000341) | 1.74976931 |
| 118 | Protruding tongue (HP:0010808) | 1.74645421 |
| 119 | Rimmed vacuoles (HP:0003805) | 1.74067145 |
| 120 | Poor eye contact (HP:0000817) | 1.73688354 |
| 121 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73414650 |
| 122 | Hypsarrhythmia (HP:0002521) | 1.72865579 |
| 123 | Abnormality of salivation (HP:0100755) | 1.72737793 |
| 124 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72448724 |
| 125 | Muscle fiber inclusion bodies (HP:0100299) | 1.71070574 |
| 126 | Cutaneous finger syndactyly (HP:0010554) | 1.69856743 |
| 127 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.69559199 |
| 128 | Intellectual disability, moderate (HP:0002342) | 1.69277227 |
| 129 | Anencephaly (HP:0002323) | 1.69191278 |
| 130 | Abnormality of the calf musculature (HP:0001430) | 1.69154910 |
| 131 | Widely spaced teeth (HP:0000687) | 1.68969210 |
| 132 | Alacrima (HP:0000522) | 1.68900165 |
| 133 | Myotonia (HP:0002486) | 1.68290213 |
| 134 | Akinesia (HP:0002304) | 1.67164030 |
| 135 | Blue irides (HP:0000635) | 1.66722643 |
| 136 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65910078 |
| 137 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.65642757 |
| 138 | Postural instability (HP:0002172) | 1.65364717 |
| 139 | Arterial tortuosity (HP:0005116) | 1.65058256 |
| 140 | Inability to walk (HP:0002540) | 1.64978854 |
| 141 | Morphological abnormality of the inner ear (HP:0011390) | 1.61762888 |
| 142 | Poor coordination (HP:0002370) | 1.61466362 |
| 143 | Gait ataxia (HP:0002066) | 1.61078591 |
| 144 | Hypoplastic left heart (HP:0004383) | 1.61031377 |
| 145 | Impaired social interactions (HP:0000735) | 1.60250519 |
| 146 | Abnormal social behavior (HP:0012433) | 1.60250519 |
| 147 | Esotropia (HP:0000565) | 1.59926844 |
| 148 | Abnormality of glycolysis (HP:0004366) | 1.59778832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.40062324 |
| 2 | CASK | 3.52572527 |
| 3 | NTRK3 | 3.39802026 |
| 4 | MAP4K2 | 2.79654130 |
| 5 | MAP3K4 | 2.46426446 |
| 6 | MAP3K9 | 2.43372300 |
| 7 | WNK3 | 2.37708843 |
| 8 | MARK1 | 2.27079066 |
| 9 | TNIK | 2.25494652 |
| 10 | MAP2K7 | 2.25377099 |
| 11 | FRK | 2.03268495 |
| 12 | OXSR1 | 2.03065582 |
| 13 | NTRK2 | 2.01511140 |
| 14 | OBSCN | 2.00559120 |
| 15 | MAPK13 | 2.00370703 |
| 16 | PRPF4B | 1.96176151 |
| 17 | PRKD3 | 1.94580150 |
| 18 | TYRO3 | 1.92456733 |
| 19 | STK39 | 1.91254976 |
| 20 | MINK1 | 1.91189789 |
| 21 | PAK6 | 1.90576542 |
| 22 | PNCK | 1.72327948 |
| 23 | KSR2 | 1.64760380 |
| 24 | PLK2 | 1.64031182 |
| 25 | PINK1 | 1.63670396 |
| 26 | ARAF | 1.60410799 |
| 27 | MAP2K4 | 1.57122555 |
| 28 | NTRK1 | 1.49071701 |
| 29 | PHKG2 | 1.42818141 |
| 30 | PHKG1 | 1.42818141 |
| 31 | BMPR2 | 1.40947094 |
| 32 | KSR1 | 1.38250626 |
| 33 | MAP3K12 | 1.34587916 |
| 34 | CDK5 | 1.28658686 |
| 35 | DAPK2 | 1.28085414 |
| 36 | SGK494 | 1.27072080 |
| 37 | SGK223 | 1.27072080 |
| 38 | CAMK2B | 1.26298718 |
| 39 | FES | 1.25745452 |
| 40 | ERBB3 | 1.24600259 |
| 41 | MAP3K13 | 1.24506802 |
| 42 | BCR | 1.23859537 |
| 43 | CAMK2A | 1.22093255 |
| 44 | FGR | 1.19404449 |
| 45 | MUSK | 1.19334590 |
| 46 | EPHA3 | 1.16774371 |
| 47 | MAP3K6 | 1.16203824 |
| 48 | CDK19 | 1.14758797 |
| 49 | PKN1 | 1.11042139 |
| 50 | CAMKK2 | 1.10527207 |
| 51 | PTK2B | 1.10089542 |
| 52 | UHMK1 | 1.08471818 |
| 53 | TRIM28 | 1.06976299 |
| 54 | MAPKAPK5 | 1.03576022 |
| 55 | GRK5 | 1.02433583 |
| 56 | NEK6 | 0.99191932 |
| 57 | LATS2 | 0.97047751 |
| 58 | PRKCG | 0.94362694 |
| 59 | STK38L | 0.93596522 |
| 60 | ROCK2 | 0.92146107 |
| 61 | FGFR2 | 0.91469716 |
| 62 | MOS | 0.91126770 |
| 63 | PAK3 | 0.91085923 |
| 64 | MAPK15 | 0.89650949 |
| 65 | CDK18 | 0.87460052 |
| 66 | CSNK1G2 | 0.85709786 |
| 67 | CDK15 | 0.84690913 |
| 68 | CAMK2D | 0.83063913 |
| 69 | BRAF | 0.82030286 |
| 70 | ERBB4 | 0.81474274 |
| 71 | CAMK1 | 0.81331532 |
| 72 | CDK14 | 0.80518715 |
| 73 | EPHB2 | 0.78680233 |
| 74 | MARK2 | 0.77686891 |
| 75 | DYRK2 | 0.77678041 |
| 76 | DYRK1A | 0.77420565 |
| 77 | ADRBK2 | 0.77144693 |
| 78 | PRKCE | 0.76289416 |
| 79 | LMTK2 | 0.75997314 |
| 80 | RAF1 | 0.74745365 |
| 81 | INSRR | 0.72619172 |
| 82 | CDK11A | 0.71876821 |
| 83 | AKT3 | 0.70326002 |
| 84 | CAMK2G | 0.69126868 |
| 85 | DMPK | 0.68445892 |
| 86 | RIPK4 | 0.67090793 |
| 87 | SGK2 | 0.66374665 |
| 88 | CAMK4 | 0.65956794 |
| 89 | CSNK1G3 | 0.65313710 |
| 90 | CCNB1 | 0.63387106 |
| 91 | DDR2 | 0.62933710 |
| 92 | DYRK1B | 0.62303874 |
| 93 | BMPR1B | 0.60739975 |
| 94 | PRKCH | 0.60272821 |
| 95 | CSNK1A1L | 0.59403192 |
| 96 | DYRK3 | 0.58593301 |
| 97 | SGK1 | 0.57978411 |
| 98 | MKNK2 | 0.57127346 |
| 99 | CAMK1G | 0.56257271 |
| 100 | PRKCZ | 0.54279633 |
| 101 | GRK1 | 0.54047124 |
| 102 | PIK3CA | 0.53487572 |
| 103 | WNK4 | 0.53411577 |
| 104 | TIE1 | 0.53085847 |
| 105 | SIK2 | 0.51598519 |
| 106 | STK38 | 0.49155520 |
| 107 | CSNK1G1 | 0.49049615 |
| 108 | DAPK1 | 0.48777491 |
| 109 | RET | 0.47825072 |
| 110 | PRKAA1 | 0.47422820 |
| 111 | CAMKK1 | 0.46717198 |
| 112 | MAP3K7 | 0.45747373 |
| 113 | STK11 | 0.43205544 |
| 114 | PDPK1 | 0.43160741 |
| 115 | TNK2 | 0.42921240 |
| 116 | ROCK1 | 0.42417709 |
| 117 | FYN | 0.42126196 |
| 118 | NME1 | 0.41691203 |
| 119 | ADRBK1 | 0.41564934 |
| 120 | WNK1 | 0.41376277 |
| 121 | ERBB2 | 0.41246119 |
| 122 | CDK3 | 0.40298220 |
| 123 | PRKACB | 0.39087595 |
| 124 | PRKG1 | 0.38909219 |
| 125 | MAPK12 | 0.38587907 |
| 126 | PRKD2 | 0.38096606 |
| 127 | GRK7 | 0.37371367 |
| 128 | RPS6KA3 | 0.37090405 |
| 129 | CSNK1D | 0.36850069 |
| 130 | PRKACA | 0.35369467 |
| 131 | LIMK1 | 0.35206688 |
| 132 | CSNK1A1 | 0.34937705 |
| 133 | TAOK3 | 0.33938248 |
| 134 | SGK3 | 0.33734697 |
| 135 | MAPK10 | 0.33221257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62903589 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.82675094 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71125672 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.58286898 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.55389362 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.44920497 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.34093769 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27443574 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.22660657 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05339691 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.00171002 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.99180327 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95328947 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 1.89647193 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85829091 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77616718 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.73446602 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70331602 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68679549 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.67420032 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63127998 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.62523025 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.47898276 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47162380 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45899776 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45381328 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45195872 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44695941 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37463751 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35161791 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28260498 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.26172164 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23380031 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20828603 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18101161 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17777155 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16717066 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16306137 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13842347 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13538428 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12396785 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11655059 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11232855 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10391310 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 1.06194427 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05183989 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.04258118 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03584049 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02154764 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01891142 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01257790 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01057504 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99123851 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.98401215 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96079516 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95221895 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93745099 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92532793 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89518656 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87811362 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87737001 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87295695 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.86914128 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86624840 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85751905 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.85694214 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84627000 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75986742 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75096684 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74642444 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.74443838 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.73258540 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73069298 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72865151 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72746441 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72238254 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71666297 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70156957 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70047439 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69953417 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68536794 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67107181 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66034840 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65326268 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64268926 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62703977 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61297623 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60924456 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60560553 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58981390 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.57974077 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56119910 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55697816 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.55327132 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54282826 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53061035 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51974534 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51398489 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51000669 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49957548 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49694317 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49264651 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48533085 |
| 104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48385923 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.48033527 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47257280 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46573988 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45793234 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45607013 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45159118 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44111776 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43430745 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42673776 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42477117 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40231472 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40209288 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39487968 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39212902 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38500375 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37469713 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37238744 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.36360139 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35185619 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.34468619 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33080807 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33070655 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31360098 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.31057616 |

